Viewing Study NCT03801304


Ignite Creation Date: 2025-12-24 @ 7:54 PM
Ignite Modification Date: 2026-01-05 @ 5:32 PM
Study NCT ID: NCT03801304
Status: COMPLETED
Last Update Posted: 2022-05-12
First Post: 2019-01-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
Sponsor: University Hospital, Brest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module